Results 191 to 200 of about 52,744 (222)

Case Report: Use of telitacicept for ocular myasthenia gravis. [PDF]

Front Immunol
Yang A, Zhao J, Li F, Pang R, Zang W.
europepmc   +1 more source

Effectiveness and safety of telitacicept in refractory ocular myasthenia gravis: a retrospective, real-world study. [PDF]

Front Immunol
Sun C, Liu D, Tang Y, Zhang B, Guo R, Gao T, Cao X, Hao S, Wang Q, Yu H, Chang T.   +10 more
europepmc   +1 more source

Thymoma-Associated Systemic Lupus Erythematosus and Myasthenia Gravis. [PDF]

Case Rep Rheumatol
González-Ramos K, Rivera-Burgos I, Cedeño C, Lafontaine J, Marcos-Martínez MJ, Vilá LM.   +5 more
europepmc   +1 more source

Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial.

JAMA Neurol
Gwathmey KG, Saccà F, Howard JF, Vu T, Xi J, Mäurer M, Ruck T, Shin HY, Takahashi MP, Casasnovas C, Smilowski M, Peric S, Masuda M, Scholz J, Shang S, Yee M, Rakhade S, Annane D.   +17 more
europepmc   +1 more source

The treatment with or without prednisolone in adults aged ≥ 70 years with myasthenia gravis: a retrospective cohort study. [PDF]

Front Neurol
Iwasa K, Furukawa Y, Yoshikawa H, Noguchi-Shinohara M, Ono K.   +4 more
europepmc   +1 more source

A Case of Concurrent Antiacetylcholine Receptor-Positive Myasthenia Gravis and Anti-HMGCR-Positive Myositis Following Statin Exposure. [PDF]

J Rheumatol
Jammal C, Newton DW, Chen C, Mammen AL.
europepmc   +1 more source

Clinical Course After a Single Cycle of Rozanolixizumab in Generalized Late-Onset Myasthenia Gravis. [PDF]

J Clin Neurol
Aritake S, Nagai A.
europepmc   +1 more source

Factors Influencing the Conversion of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis: A Retrospective Cohort Study. [PDF]

J Ophthalmol
Chuenkongkaew W, Chirapapaisan N, Chatchutimakorn P, Rattanathamsakul N, Joradoln M, Kongthanasomboon P, Eiamsamarng A.   +6 more
europepmc   +1 more source